2016-2018
- Professor Jor-Kai Lin’s team at Taipei Medical University and Dr. Jin-Sheng Hong from Shuang Ho Hospital initiated clinical recruitment for breast cancer methylation testing.
- Participated in the Ministry of Science and Technology SPARK TAIWAN program.
- Professor Jor-Kai Lin’s team at Taipei Medical University developed a colorectal cancer blood-based cfDNA methylation test.
2019-2021
- Research Projects
- University-Industry Innovation R&D Program
- National Science Council Seed Grant Program
- Awards & Patents
- Top 20 in the FITI Innovation Competition by the Ministry of Science and Technology
- Future Tech Breakthrough Award
- National Innovation Award
- Breast cancer blood-based methylation test patent granted in Taiwan
2022
- Funding & Establishment
- Completed seed funding round
- EG BioMed Inc. officially established
- Technology transferred from Taipei Medical University to EG BioMed
- Industry-Academia cooperation project commission, conducting recruitment for cancer detection testing
2023
- Technical Breakthroughs
- Developed cfDNA methylation detection technology for pancreatic and lung cancer, with patent layout
- Industry-academia collaboration project for innovative demethylation drug development
- Awards & Patents
- National Startup Innovation Award
- Breast cancer methylation test granted EU patent, covering 19 EU countries
- Colorectal cancer methylation test granted Taiwan patent
- Overseas Market Expansion
- Established Australian subsidiary EG BioMed AU Pty Ltd
2024
- Technical Breakthroughs
- Aging DNA Methylation Blood Test (EG-Aging Test)
- Development of blood tests for four major cancers
- Breast cancer cfDNA methylation test under FDA De Novo substantive review
- CAP certification submitted to the College of American Pathologists
- Breast cancer methylation test patents granted in Malaysia, China, and Japan
- New drug development for pancreatic cancer
- Taiwan Market Strategy
- Established EG Clinical Laboratory
- EG Clinical Laboratory’s breast and pancreatic cancer blood tests certified by ISO15189 TAF medical laboratory accreditation
- EG Clinical Laboratory LDTs certification obtained
- U.S. Market Expansion
- Established U.S. subsidiary EG BioMed US Inc.
- Established EG BioMed US Laboratory in Seattle
2025
- International Certifications & Patent Milestones
- EG BioMed US Laboratory received CLIA certification
- Breast cancer blood test granted patents in the U.S. and Singapore
- Pancreatic cancer blood test granted U.S. patent